Besides Covaxin, BharatBiotech has been actively working on developing
another vaccine, for which it tied up with Washington UniversitySchool
of Medicine in St Louis for the novel "chimp-adenovirus" (Chimpanzee
adenovirus), a single dose intranasal vaccine for COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-start-phase-1-trials-of-covid-19-intranasal-vaccine-in-feb-march/articleshow/80166140.cms
No comments:
Post a Comment